Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Myung-Ho | - |
dc.contributor.author | Kim, Hwan | - |
dc.contributor.author | Choi, Won-Kyoung | - |
dc.contributor.author | El-Gamal, Mohammed I. | - |
dc.contributor.author | Park, Jin-Hun | - |
dc.contributor.author | Yoo, Kyung Ho | - |
dc.contributor.author | Sim, Tae Bo | - |
dc.contributor.author | Lee, So Ha | - |
dc.contributor.author | Baek, Daejin | - |
dc.contributor.author | Hah, Jung-Mi | - |
dc.contributor.author | Cho, Jung-Hyuck | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2021-06-23T14:39:48Z | - |
dc.date.available | 2021-06-23T14:39:48Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2009-12 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/40611 | - |
dc.description.abstract | Synthesis of a new series of diarylureas and amides having pyrrolo[2,3-d]pyrimidine scaffold is described. Their in vitro antiproliferative activities against A375 human melanoma cell line and HS 27 fibroblast cell line were tested and the effect of substituents on pyrrolo[2,3-d]pyrimidine was investigated. The newly synthesized compounds, except N-acetyl derivatives (Id, Ie, and Im), generally showed superior or similar activity against A375 to Sorafenib. Among all of these derivatives, compounds Iq and Ir having imidazole and morpholine moieties, respectively, showed the most potent antiproliferative activity against A375. (C) 2009 Published by Elsevier Ltd. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hah, Jung-Mi | - |
dc.identifier.doi | 10.1016/j.bmcl.2009.10.051 | - |
dc.identifier.scopusid | 2-s2.0-71749118193 | - |
dc.identifier.wosid | 000271430400008 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.19, no.23, pp.6538 - 6543 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 19 | - |
dc.citation.number | 23 | - |
dc.citation.startPage | 6538 | - |
dc.citation.endPage | 6543 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | REFRACTORY SOLID TUMORS | - |
dc.subject.keywordPlus | FACTOR RECEPTOR INHIBITOR | - |
dc.subject.keywordPlus | RAF KINASE | - |
dc.subject.keywordPlus | SUBSTITUTED UREAS | - |
dc.subject.keywordPlus | PHASE-I | - |
dc.subject.keywordPlus | BAY-43-9006 | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | INTERLEUKIN-2 | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordAuthor | Pyrrolo[2,3-d]pyrimidine | - |
dc.subject.keywordAuthor | A375 | - |
dc.subject.keywordAuthor | HS 27 | - |
dc.subject.keywordAuthor | Antiproliferative activity | - |
dc.subject.keywordAuthor | Melanoma | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0960894X09014528?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.